Adaptimmune Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%)等
Adaptimmune Therapeutics | 3:首次持股声明-股东 EcoR1 Capital, LLC
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%)等
Adaptimmune Therapeutics | 4:持股变动声明-高管 Piccina Cintia
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%)等
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%)等
Adaptimmune Therapeutics | SC 13G:超过5%持股股东披露文件-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%)等
Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baillie Gifford & Co (Scottish partnership)(7.01%)
Adaptimmune Therapeutics | 4:持股变动声明-高管 Rawcliffe Adrian
Adaptimmune Therapeutics | 4:持股变动声明-高管 Bertrand William C JR
Adaptimmune Therapeutics | 4:持股变动声明-高管 Lunger John
Adaptimmune Therapeutics | 4:持股变动声明-高管 Norry Elliot
Adaptimmune Therapeutics | 4:持股变动声明-董事 Behbahani Ali
Adaptimmune Therapeutics | 4:持股变动声明-高管 Bertrand William C JR
Adaptimmune Therapeutics | 4:持股变动声明-董事 Hege Kristen
Adaptimmune Therapeutics | 4:持股变动声明-高管 Lunger John
Adaptimmune Therapeutics | 4:持股变动声明-高管 Brewer Joanna Elizabeth
Adaptimmune Therapeutics | 4:持股变动声明-高管 TAYTON-MARTIN HELEN KATRINA
Adaptimmune Therapeutics | 4:持股变动声明-高管 Rawcliffe Adrian
Adaptimmune Therapeutics | 4:持股变动声明-高管 Norry Elliot
暂无数据